BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21631396)

  • 21. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
    Lee JH; Jung HS; Giang PM; Jin X; Lee S; Son PT; Lee D; Hong YS; Lee K; Lee JJ
    J Pharmacol Exp Ther; 2006 Jan; 316(1):271-8. PubMed ID: 16183703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT.
    Whisler RL; Beiqing L; Chen M
    Cell Immunol; 1996 May; 169(2):185-95. PubMed ID: 8620546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-kappaB mediates MPP+-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1.
    Yang HJ; Wang L; Xia YY; Chang PN; Feng ZW
    Neurochem Int; 2010 Jan; 56(1):128-34. PubMed ID: 19778565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
    Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
    Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells.
    Beiqing L; Chen M; Whisler RL
    J Immunol; 1996 Jul; 157(1):160-9. PubMed ID: 8683110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1.
    Jutz S; Leitner J; Schmetterer K; Doel-Perez I; Majdic O; Grabmeier-Pfistershammer K; Paster W; Huppa JB; Steinberger P
    J Immunol Methods; 2016 Mar; 430():10-20. PubMed ID: 26780292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of RelA phosphorylation sensitizes apoptosis in constitutive NF-kappaB-expressing and chemoresistant cells.
    Manna SK; Manna P; Sarkar A
    Cell Death Differ; 2007 Jan; 14(1):158-70. PubMed ID: 16645640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of two forms of TNF tolerance in human monocytes: differential inhibition of NF-κB/AP-1- and PP1-associated signaling.
    Günther J; Vogt N; Hampel K; Bikker R; Page S; Müller B; Kandemir J; Kracht M; Dittrich-Breiholz O; Huber R; Brand K
    J Immunol; 2014 Apr; 192(7):3143-55. PubMed ID: 24574500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IκB kinase β is required for activation of NF-κB and AP-1 in CD3/CD28-stimulated primary CD4(+) T cells.
    Lupino E; Ramondetti C; Piccinini M
    J Immunol; 2012 Mar; 188(6):2545-55. PubMed ID: 22331067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aplotaxene blocks T cell activation by modulation of protein kinase C-θ-dependent pathway.
    Na BR; Kim HR; Kwon MS; Lee HS; Piragyte I; Choi EJ; Choi HK; Han WC; Lee SH; Jun CD
    Food Chem Toxicol; 2013 Dec; 62():23-31. PubMed ID: 23941771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PKCtheta and Itk functionally interact during primary mouse CD3+ T cell activation.
    Thuille N; Lutz-Nicoladoni C; Letschka T; Hermann-Kleiter N; Heit I; Baier G
    Immunol Lett; 2009 Sep; 126(1-2):54-9. PubMed ID: 19682494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.
    Gringhuis SI; de Leij LF; Verschuren EW; Borger P; Vellenga E
    Blood; 1997 Oct; 90(7):2690-700. PubMed ID: 9326236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells.
    Martínez-Martínez S; Gómez del Arco P; Armesilla AL; Aramburu J; Luo C; Rao A; Redondo JM
    Mol Cell Biol; 1997 Nov; 17(11):6437-47. PubMed ID: 9343406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of NF-κB by opioids in T cells.
    Börner C; Kraus J
    J Immunol; 2013 Nov; 191(9):4640-7. PubMed ID: 24068670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of interleukin-2 production by CD4(+) T cells expressing TIM-3 through suppression of NFAT dephosphorylation and AP-1 transcription.
    Lee MJ; Woo MY; Chwae YJ; Kwon MH; Kim K; Park S
    Immunobiology; 2012 Oct; 217(10):986-95. PubMed ID: 22445722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-substituted benzamides inhibit nuclear factor-kappaB and nuclear factor of activated T cells activity while inducing activator protein 1 activity in T lymphocytes.
    Lindgren H; Pero RW; Ivars F; Leanderson T
    Mol Immunol; 2001 Aug; 38(4):267-77. PubMed ID: 11566320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells.
    Aoki Y; Kao PN
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2678-84. PubMed ID: 10543746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell permeable NFAT inhibitory peptide Sim-2-VIVIT inhibits T-cell activation and alleviates allergic airway inflammation and hyper-responsiveness.
    Choi JM; Sohn JH; Park TY; Park JW; Lee SK
    Immunol Lett; 2012 Apr; 143(2):170-6. PubMed ID: 22342853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudoephedrine alleviates atopic dermatitis-like inflammatory responses in vivo and in vitro.
    Chen X; Lin J; Liang Q; Chen X; Wu Z
    Life Sci; 2020 Oct; 258():118139. PubMed ID: 32721463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptome analysis of the human T lymphocyte cell line Jurkat and human peripheral blood mononuclear cells exposed to deoxynivalenol (DON): New mechanistic insights.
    Katika MR; Hendriksen PJ; Shao J; van Loveren H; Peijnenburg A
    Toxicol Appl Pharmacol; 2012 Oct; 264(1):51-64. PubMed ID: 22846391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.